Kristine Elizabeth Weber, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 W Lake St, Hanover Park, IL 60133 Phone: 630-556-2000 |
More Than Words Therapy Services, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2211 Camden Ln, Hanover Park, IL 60133 Phone: 708-612-8362 Fax: 847-893-6714 |
Joanna Magana, M.S., SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 W Lake St, Hanover Park, IL 60133 Phone: 630-556-2000 |
Amanda Suzanne Aubry, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5208 Arlington Cir, Hanover Park, IL 60133 Phone: 630-894-4638 |
Teresa Joerger Davis, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1515 E Lake St, Hanover Park, IL 60133 Phone: 847-366-2417 |
Kelly A Cunningham Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1451 Cypress Ave, Hanover Park, IL 60133 Phone: 847-357-2090 |
Kristin Marie Esia, MA CCC SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7486 Filmore Ave, Hanover Park, IL 60133 Phone: 773-332-4412 |
Julia R White, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 W Lake St, Hanover Park, IL 60133 Phone: 630-556-2000 |
Mrs. Constance Lynn Ford, ED.D.,SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5768 Edison Cir, Hanover Park, IL 60133 Phone: 630-205-1452 |
News Archive
Researchers have uncovered how genes identified from genome-wide association studies (GWAS) affect high-density lipoprotein cholesterol (HDL-C), a biomarker of cardiovascular disease, after comparing several animal models with human patient data.
Cephalon, Inc. today announced that the U.S. Food and Drug Administration (FDA) has extended the action date to March 29, 2010, for its review of the supplemental New Drug Application (sNDA) for NUVIGIL® (armodafinil) Tablets [C-IV].
Assessing glomerular filtration rate (GFR) using kidney filtration markers in blood is the standard means for determining kidney function, diagnosing kidney disease and measuring its progression. A higher filtration rate indicates healthy kidney function, while a lower rate points to various stages of kidney disease. A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that the new CKD-EPI equation for calculating GFR is a better predictor of risk for kidney disease and death compared to the most widely used method. The findings suggest that switching to the CKD-EPI equation for calculating GFR could focus efforts more efficiently, and improve assessment of patient future risk and treatment of kidney disease. The study is published in the May 9 edition of JAMA.
AstraZeneca today announced a two-year research collaboration with the University of Michigan to advance the treatment of chronic kidney disease (CKD) through the improved understanding of the disease. The collaboration will tackle the challenging area of identifying novel targets for the treatment of CKD, focusing on the use ofpatient tissue and validation of preclinical models.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in biomedical imaging, today announced the launch of inFormâ„¢, advanced image analysis software based on the company's proprietary Machine Learning System (MLS). inForm solves biologists' and cancer researchers' challenging image analysis problems by combining fast and easy-to-use automated image processing with advanced learning features that enable the user to train the software to process images automatically.
› Verified 6 days ago